MRS. MAYLING CHIN CHU MD
Prescription History 1801934021
Ophthalmology in Brooklyn, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. MAYLING CHIN CHU MD, an active Ophthalmology specialist practicing in Brooklyn, NY. Our medical registry currently tracks 30 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,412 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 573 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Latanoprost | 573 | $24.58 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 573 Medicare prescriptions for Latanoprost, about 3.8 times the volume of the typical New York prescriber of this medication (149). Medicare paid an average of $24.58 per fill, versus $20.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,368.4 30-Day Fills standardized to 30-day supplies 40,598 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 355 | $529.77 | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 355 Medicare prescriptions for Lumigan, about 4.6 times the volume of the typical New York prescriber of this medication (77). Medicare paid an average of $529.77 per fill, versus $492.27 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 708.9 30-Day Fills standardized to 30-day supplies 20,762 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 178 | $83.98 | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 178 Medicare prescriptions for Timolol Maleate, about 2.5 times the volume of the typical New York prescriber of this medication (70). Medicare paid an average of $83.98 per fill, versus $38.85 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 405.1 30-Day Fills standardized to 30-day supplies 12,026 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 156 | $24.60▼ below NY avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 156 Medicare prescriptions for Dorzolamide-Timolol, about 1.7 times the volume of the typical New York prescriber of this medication (90). Medicare paid an average of $24.60 per fill, versus $32.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 278.2 30-Day Fills standardized to 30-day supplies 8,333 Days of Medication total across all patients in 2023 | |||
| Travoprost | 118 | $294.93 | ▲ More than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 118 Medicare prescriptions for Travoprost, about 3.4 times the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $294.93 per fill, versus $266.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 229.8 30-Day Fills standardized to 30-day supplies 6,792 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 114 | $15.84▼ below NY avg | ▲ More than typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 114 Medicare prescriptions for Erythromycin, about 2.1 times the volume of the typical New York prescriber of this medication (54). Medicare paid an average of $15.84 per fill, versus $19.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 153.8 30-Day Fills standardized to 30-day supplies 3,352 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 102 | $1,208.46 | ≈ Typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 102 Medicare prescriptions for Restasis, about the same volume as the typical New York prescriber of this medication (93). Medicare paid an average of $1,208.46 per fill, versus $1,034.99 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 178 30-Day Fills standardized to 30-day supplies 5,340 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 96 | $464.99 | ▲ More than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 96 Medicare prescriptions for Combigan, about 1.8 times the volume of the typical New York prescriber of this medication (52). Medicare paid an average of $464.99 per fill, versus $403.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 183.2 30-Day Fills standardized to 30-day supplies 5,415 Days of Medication total across all patients in 2023 | |||
| VyzultaLatanoprostene Bunod | 92 | $492.98 | ▲ More than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 92 Medicare prescriptions for Vyzulta, about 1.9 times the volume of the typical New York prescriber of this medication (48). Medicare paid an average of $492.98 per fill, versus $412.09 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 149.7 30-Day Fills standardized to 30-day supplies 4,183 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 87 | $549.38 | ▲ More than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 87 Medicare prescriptions for Alphagan P, about 1.8 times the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $549.38 per fill, versus $396.46 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 209.6 30-Day Fills standardized to 30-day supplies 6,203 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 80 | $14.30▼ below NY avg | ▲ More than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 80 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about 1.6 times the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $14.30 per fill, versus $14.55 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 86 30-Day Fills standardized to 30-day supplies 1,181 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 59 | $1,449.46 | ≈ Typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 59 Medicare prescriptions for Xiidra, about 1.2 times the volume of the typical New York prescriber of this medication (50). Medicare paid an average of $1,449.46 per fill, versus $945.82 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 121 30-Day Fills standardized to 30-day supplies 3,630 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 59 | $93.46 | ≈ Typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 59 Medicare prescriptions for Brimonidine Tartrate, about the same volume as the typical New York prescriber of this medication (61). Medicare paid an average of $93.46 per fill, versus $70.70 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 121.7 30-Day Fills standardized to 30-day supplies 3,596 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 41 | $31.70 | ≈ Typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 41 Medicare prescriptions for Dorzolamide Hcl, about 85% of the volume of the typical New York prescriber of this medication (48). Medicare paid an average of $31.70 per fill, versus $30.75 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 100.7 30-Day Fills standardized to 30-day supplies 3,020 Days of Medication total across all patients in 2023 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 41 | $60.73▼ below NY avg | ≈ Typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye. In 2023, this provider wrote 41 Medicare prescriptions for Tobramycin-Dexamethasone, about the same volume as the typical New York prescriber of this medication (41). Medicare paid an average of $60.73 per fill, versus $81.44 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 53.9 30-Day Fills standardized to 30-day supplies 1,324 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 28 | $460.08 | ≈ Typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 28 Medicare prescriptions for Simbrinza, about 82% of the volume of the typical New York prescriber of this medication (34). Medicare paid an average of $460.08 per fill, versus $261.48 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 53.4 30-Day Fills standardized to 30-day supplies 1,602 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 24 | $58.65 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 24 Medicare prescriptions for Prednisolone Acetate, about 18% of the volume of the typical New York prescriber of this medication (135). Medicare paid an average of $58.65 per fill, versus $52.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43.3 30-Day Fills standardized to 30-day supplies 1,240 Days of Medication total across all patients in 2023 | |||
| Loteprednol Etabonate | 23 | $362.75 | ▼ Less than typical |
About Loteprednol Etabonate: This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Show more ▾ Loteprednol belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2023, this provider wrote 23 Medicare prescriptions for Loteprednol Etabonate, about 70% of the volume of the typical New York prescriber of this medication (33). Medicare paid an average of $362.75 per fill, versus $214.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43.7 30-Day Fills standardized to 30-day supplies 1,297 Days of Medication total across all patients in 2023 | |||
| Difluprednate | 22 | $139.93▼ below NY avg | ▼ Less than typical |
About Difluprednate: This medication is used to treat swelling and pain after eye surgery. Show more ▾ It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 22 Medicare prescriptions for Difluprednate, about half the volume of the typical New York prescriber of this medication (40). Medicare paid an average of $139.93 per fill, versus $152.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 22 30-Day Fills standardized to 30-day supplies 517 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 20 | $299.85▼ below NY avg | ▼ Less than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 20 Medicare prescriptions for Brinzolamide, about 65% of the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $299.85 per fill, versus $343.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2023 | |||
| LotemaxLoteprednol Etabonate | 18 | $460.02 | ▼ Less than typical |
About Lotemax: This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Show more ▾ Loteprednol belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2023, this provider wrote 18 Medicare prescriptions for Lotemax, about 72% of the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $460.02 per fill, versus $368.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.1 30-Day Fills standardized to 30-day supplies 576 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 17 | $980.58 | ▼ Less than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 17 Medicare prescriptions for Rocklatan, about a third of the volume of the typical New York prescriber of this medication (41). Medicare paid an average of $980.58 per fill, versus $517.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 42 30-Day Fills standardized to 30-day supplies 1,255 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 16 | $39.68 | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 16 Medicare prescriptions for Ketorolac Tromethamine, about 16% of the volume of the typical New York prescriber of this medication (99). Medicare paid an average of $39.68 per fill, versus $26.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24.5 30-Day Fills standardized to 30-day supplies 694 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 15 | $185.80 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 15 Medicare prescriptions for Dorzolamide-Timolol, about 17% of the volume of the typical New York prescriber of this medication (90). Medicare paid an average of $185.80 per fill, versus $32.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2023 | |||
| Cosopt PfDorzolamide/Timolol/Pf | 15 | $327.03 | ▼ Less than typical |
About Cosopt Pf: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 15 Medicare prescriptions for Cosopt Pf, about 65% of the volume of the typical New York prescriber of this medication (23). Medicare paid an average of $327.03 per fill, versus $288.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2023 | |||
| Fluorometholone | 14 | $129.78 | ▼ Less than typical |
About Fluorometholone: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Fluorometholone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) In 2023, this provider wrote 14 Medicare prescriptions for Fluorometholone, about a quarter of the volume of the typical New York prescriber of this medication (53). Medicare paid an average of $129.78 per fill, versus $83.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21.2 30-Day Fills standardized to 30-day supplies 625 Days of Medication total across all patients in 2023 | |||
| Methazolamide | 13 | $365.56▼ below NY avg | ▼ Less than typical |
About Methazolamide: This medication is used to treat high pressure inside the eye due to certain types of glaucoma. Show more ▾ Lowering high pressure inside the eye helps to prevent blindness, vision loss, and nerve damage. Methazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma. In 2023, this provider wrote 13 Medicare prescriptions for Methazolamide, about half the volume of the typical New York prescriber of this medication (30). Medicare paid an average of $365.56 per fill, versus $369.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 18.4 30-Day Fills standardized to 30-day supplies 550 Days of Medication total across all patients in 2023 | |||
| Doxycycline Hyclate | 13 | $15.77▼ below NY avg | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2023, this provider wrote 13 Medicare prescriptions for Doxycycline Hyclate, about half the volume of the typical New York prescriber of this medication (28). Medicare paid an average of $15.77 per fill, versus $23.85 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 13 30-Day Fills standardized to 30-day supplies 322 Days of Medication total across all patients in 2023 | |||
| Acetazolamide ErAcetazolamide | 12 | $66.29▼ below NY avg | ▼ Less than typical |
About Acetazolamide Er: Acetazolamide is used to prevent and reduce the symptoms of altitude sickness. Show more ▾ This medication can decrease headache, tiredness, nausea, dizziness, and shortness of breath that can occur when you climb quickly to high altitudes (generally above 10,000 feet/3,048 meters). It is particularly useful in situations when you cannot make a slow ascent. The best ways to prevent altitude sickness are climbing slowly, stopping for 24 hours during the climb to allow the body to adjust to the new height, and taking it easy the first 1 to 2 days. This medication is also used with other medications to treat high pressure inside the eye due to certain types of glaucoma. Acetazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. It is also used to decrease a buildup of body fluids (edema) caused by heart failure or certain medications. Acetazolamide can work less well over time, so it is usually used only for a short period. It has also been used with other medications to treat certain types of seizures (petit mal and unlocalized seizures). One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) In 2023, this provider wrote 12 Medicare prescriptions for Acetazolamide Er, about half the volume of the typical New York prescriber of this medication (27). Medicare paid an average of $66.29 per fill, versus $83.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| ProlensaBromfenac Sodium | 11 | $380.22 | ▼ Less than typical |
About Prolensa: This medication is used to treat swelling (inflammation) and pain in the eye after a certain type of eye surgery (cataract surgery). Show more ▾ Bromfenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation. In 2023, this provider wrote 11 Medicare prescriptions for Prolensa, about 16% of the volume of the typical New York prescriber of this medication (70). Medicare paid an average of $380.22 per fill, versus $355.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MRS. MAYLING CHIN CHU MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Brooklyn, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
